Listen Here:
Click or simply search “Sigma Nutrition” on your podcast platform of choice.
Or listen directly on the Sigma website here.
Introduction
In clinical practice effective nutrition, exercise, and obesity care is rarely about identifying the single “best” plan on paper. Instead, sustainable change depends on behavioral psychology: understanding the person’s context, motivation, barriers, and patterns, then co-designing practical steps that can actually be implemented in real life.
David Creel PhD, RD is a clinical psychologist and registered dietitian working in weight management at the Cleveland Clinic. Dr. Creel discusses how clinicians can bridge the gap between “optimal recommendations” and what is most likely to create actual behaviour change. This includes a combination of using collaborative communication, self-monitoring, skill-building, relapse prevention planning, and a multidisciplinary framework.
Behavioral and psychological factors shape food choices, physical activity, and adherence far more than knowing the newest guideline. In addition, the modern obesity treatment landscape (including GLP-1 receptor agonists) increases the need for structured behavior-change support: people may experience new hope and new fear (especially fear of weight regain), and the key clinical question becomes how to use these tools to build durable habits and reduce relapse risk over the long term.
Related resources
- Join the Sigma newsletter for free
- Subscribe to Sigma Nutrition Premium
- Enroll in the next cohort of our Applied Nutrition Literacy course
- LinkedIn:
- X/Twitter:
- [03:09]Start of interview
- [05:31]Challenges in nutrition and exercise recommendations
- [11:01]Behavior change in real-world practice
- [16:32]Self-monitoring and its importance
- [23:48]Non-scale victories and positive body image
- [25:58]Focusing on body capabilities over aesthetics
- [27:20]Integrating activity into lifestyle
- [30:30]Exercise snacking and practical tips
- [33:36]Impact of GLP-1 receptor agonists
- [38:24]Addressing fear of weight regain
- [41:24]Effective multidisciplinary obesity treatment
Guest Information
Click through to your app of choice to listen and subscribe:
Dr. David Creel works in the Department of Endocrinology at the Cleveland Clinic. He provides lifestyle interventions for patients affected by obesity.
He is a licensed psychologist, an ACSM Certified Clinical Exercise Physiologist, a registered dietitian (RD), and a certified diabetes care and education specialist (CDCES). He completed his PhD from Louisiana State University while working at the Pennington Biomedical Research Center.
Dr. Creel’s primary research interests and publications have focused on promoting physical activity among bariatric surgery patients.
Danny Lennon has a master’s degree (MSc.) in Nutritional Sciences from University College Cork, and he is the founder of Sigma Nutrition.
Danny is currently a member of the Advisory Board of the Sports Nutrition Association, the global regulatory body responsible for the standardisation of best practice in the sports nutrition profession.
Introduction to this Episode
In clinical practice effective nutrition, exercise, and obesity care is rarely about identifying the single “best” plan on paper. Instead, sustainable change depends on behavioral psychology: understanding the person’s context, motivation, barriers, and patterns, then co-designing practical steps that can actually be implemented in real life.
David Creel PhD, RD is a clinical psychologist and registered dietitian working in weight management at the Cleveland Clinic. Dr. Creel discusses how clinicians can bridge the gap between “optimal recommendations” and what is most likely to create actual behaviour change. This includes a combination of using collaborative communication, self-monitoring, skill-building, relapse prevention planning, and a multidisciplinary framework.
Behavioral and psychological factors shape food choices, physical activity, and adherence far more than knowing the newest guideline. In addition, the modern obesity treatment landscape (including GLP-1 receptor agonists) increases the need for structured behavior-change support: people may experience new hope and new fear (especially fear of weight regain), and the key clinical question becomes how to use these tools to build durable habits and reduce relapse risk over the long term.
